13569.rar – Full

Research into PRAME as an immunotherapy target in sarcoma subtypes.

The provided search results do not contain an article named "13569.rar" directly. However, they indicate this number is likely part of an identifier for research regarding , specifically Dedifferentiated Liposarcoma (DDLPS) , a common form of soft tissue tumor. 13569.rar

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma Research into PRAME as an immunotherapy target in

Based on your request, "13569.rar" appears to be a file identifier, likely associated with scientific or medical research datasets. Genomic alterations and clinical outcomes in patients with

Other related research topics often found in similar databases include:

This research, likely part of the dataset, analyzed tumor sequencing to identify the amplification of genes such as MDM2 and CDK4 in 12q14-15. It connects these molecular findings to survival and metastasis rates in patients, noting that MDM2 amplification is a key marker distinguishing DDLPS from benign tumors.

Analysis of DNA methylation patterns affecting chemo-resistance in sarcoma patients.

Research into PRAME as an immunotherapy target in sarcoma subtypes.

The provided search results do not contain an article named "13569.rar" directly. However, they indicate this number is likely part of an identifier for research regarding , specifically Dedifferentiated Liposarcoma (DDLPS) , a common form of soft tissue tumor.

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

Based on your request, "13569.rar" appears to be a file identifier, likely associated with scientific or medical research datasets.

Other related research topics often found in similar databases include:

This research, likely part of the dataset, analyzed tumor sequencing to identify the amplification of genes such as MDM2 and CDK4 in 12q14-15. It connects these molecular findings to survival and metastasis rates in patients, noting that MDM2 amplification is a key marker distinguishing DDLPS from benign tumors.

Analysis of DNA methylation patterns affecting chemo-resistance in sarcoma patients.